טוען...
Antiviral nanoagents: More attention and effort needed?
The recent COVID-19 outbreak has increasingly engaged researchers in the search for effective antiviral drugs as well as therapeutic treatment options. The shortcomings of existing antiviral agents such as narrow spectrum and low bioavailability, can be overcome through the use of engineered nanomat...
שמור ב:
| הוצא לאור ב: | Nano Today |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier Ltd.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7498411/ https://ncbi.nlm.nih.gov/pubmed/32963581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nantod.2020.100976 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|